Cytotheryx is a biomedical research company focused on the development of a consistent, high-quality source of human hepatocytes (HHCs) ...
Location: United States
Employees: 11-50
Total raised: $60M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Enterprise... | sdei.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.01.2026 | Series A | $60M | - |
Mentions in press and media 7
| Date | Title | Description |
| 19.01.2026 | Cytotheryx Raises $60M in Series A Funding | Cytotheryx, Inc., a Rochester, MN-based preclinical cell therapy company developing treatments for liver disease, raised $60M in Series A funding. The round was led by Ouroboros Family Founders Fund I, LP. The company intends to use the fun... |
| 16.01.2026 | Cytotheryx: $60 Million Series A Closed To Advance Cell Therapy Platform For Liver Disease | Ouroboros Family Founders Fund I has agreed to lead a $60 million Series A financing for Cytotheryx, a Mayo Clinic spinout developing a preclinical cell therapy platform to treat liver disease, with the deal unveiled during the 2026 Biotech... |
| 13.01.2026 | Cytotheryx Secures $60M Series A, Boosts Liver Cell Therapy Development | Cytotheryx, a preclinical cell therapy firm, secured $60 million in Series A funding. Ouroboros Family Founders Fund I led the round. Significant debt financing from QRS Investments boosts facility and GMP manufacturing expansion. This Mayo... |
| 12.01.2026 | Cytotheryx Lands Lead For $60 Million Series A And Adds Debt Financing To Expand Facilities | Cytotheryx, a preclinical cell therapy company developing cell-based treatments for liver disease, said it has secured a lead term sheet for a $60 million Series A round and lined up additional debt financing aimed at expanding its manufact... |
| 12.01.2026 | Cytotheryx Raises $60M in Series A Funding | Cytotheryx, Inc. , a Rochester, MN-based preclinical cell therapy company developing cell-based treatments for liver disease, raised $60M in Series A funding. The round was led by Ouroboros Family Founders Fund I. In parallel, Cytotheryx se... |
| 23.02.2023 | Cytotheryx, Inc. Announces Acquisition of Ambys Medicines, Inc. Intellectual Property Assets | ROCHESTER, MN, USA, February 23, 2023 /EINPresswire.com/ -- Cytotheryx, Inc. announced today it has acquired the intellectual property assets of Ambys Medicines, Inc. These technologies will now become a part of the Rochester, Minnesota-bas... |
| - | Cytotheryx | “Help us create a future without liver disease. Our platform technology allows human liver cells to be created in quantity and quality that has never been achievable before. There’s a great and growing need for functional liver cells (hepat... |